Loading clinical trials...

Phenotype and Burden of a Midfacial Segment Pain | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATION

Phenotype and Burden of a Midfacial Segment Pain

Cross-sectional, Multicentre and Multidisciplinary Study Describing Phenotype and Burden of a Midfacial Segment Pain

NCT06299995•Swiat Zdrowia

Summary

The purpose of this study is to describe midfacial segment pain phenotype, burden and comorbidities in a multicentre and multidisciplinary setting. The ultimate goal is a comprehensive description of this type of pain allowing for its implementation in future classifications. This cross-sectional study is designed to describe midfacial segment pain in a clinical setting. Patients from rhinologic, headache and facial pain or oral medicine/dentistry secondary care centres will be recruited during a one year period. Individuals with other facial pain according to current classification such as sinonasal disorders, neoplasms, local infections, history of significant trauma associated with pain onset will be excluded. Data will be collected through a structured questionnaire covering pain characteristics, coexisting diagnoses, pain-related burden and consequences, physical examination and paranasal sinuses imaging.

Detailed Description

https://journals.sagepub.com/doi/10.1177/25158163241235642

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•The study will include patients consulting rhinologic, oral medicine/dentistry, headache or pain specialists because of facial pain with the following features:
•located at least partially within an area innervated by the second or third division of the trigeminal nerve (both bilateral and unilateral)
•duration of attacks of \> 5 minutes and \< 1 month
•attacks recur for \> 1 month
•at least one pain-free day per month (this pain-free day must be unrelated to the use of abortive or prophylactic treatment modalities).

Exclusion Criteria

•1. Facial pain can be attributed to other ICOP-1 diagnosis, apart from tension-type orofacial pain. This means that investigators should exclude especially:
•* facial migraine by ensuring that facial pain is not accompanied by either migraine aura AND/OR nausea/vomiting AND/OR photo- and phonophobia
•* persistent idiopathic facial pain by ensuring that the patient experienced a pain-free day or days in the last month (this day or days must be unrelated to use of abortive or prophylactic treatment modalities).
•* stomatognathic disorders incl. myofascial orofacial pain (chapter 1-3 of ICOP-1) by ensuring that pain is neither unrelated to jaw motion, function or parafunction nor that signs of temporomandibular disorders are present on physical examination.
•2. Facial pain with clear rhinogenic cause, such as acute and chronic rhinosinusitis fulfilling both clinical and endoscopic/imaging diagnostic criteria according to the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS 2020).
•3. Facial pain that can be attributed to neoplasms.
•4. Facial pain that can be attributed to local infection including post-herpetic neuralgia.
•5. History of significant trauma associated with pain onset (pain developed within 7 days from trauma).
•Patients who additionally and independently suffer from primary headaches whose mid-facial pain cannot be explained as orofacial headaches are explicitly not excluded. In other words, patients with migraine are not excluded, as long as their facial pain has no typical migraine features (i.e. nausea/vomiting, photo- AND phonophobia or aura) and facial pain attacks occur independently of headache episodes.
•Also, patients showing signs of mucosal contact points or deviated nasal septum will be included, but the presence of these conditions should be noted in the patients' history. Moreover, patients with Lund-Mackay score of 4 or less can be included in the study, unless any singular sinus can be scored with 2 points.

Locations (13)

Department of Otolaryngology, University of Malta

Msida, Malta

Athleticomed - Pain&Headache Treatment Centre

Bydgoszcz, Poland

Department of Otolaryngology, Head and Neck Surgery and Laryngological Oncology

Bydgoszcz, Poland

Department of Neurology, Jagiellonian University Medical College

Krakow, Poland

Świat Zdrowia

Orzyny, Poland

Department of Neurology and Restorative Medicine, Health Institute dr Boczarska-Jedynak

Oświęcim, Poland

4. Department of Otorhinolaryngology, National Institute of Medicine of the Ministry of the Interior and Administration

Warsaw, Poland

5. Department of Otolaryngology, Centre of Postgraduate Medical Education

Warsaw, Poland

Department of Experimental Dentistry, Wroclaw Medical University

Wroclaw, Poland

Department of Neurology, Wroclaw Medical University

Wroclaw, Poland

Key Dates

Start Date

February 24, 2024

Primary Completion Date

March 31, 2025

Completion Date

March 31, 2025

Last Updated

March 19, 2024

Enrollment

200

ESTIMATED participants

Conditions

Facial Pain

Feasibility Testing of the "Face-Forward-Web" Program for Chronic Orofacial Pain

NCT06754917

Orofacial PainFacial Pain

View study

RECRUITINGNA

Effect of Occlusal Splint on Head and Neck Muscles in Patients With Bruxism and Myofascial Pain

NCT07090551

Myofacial Pain SyndromeLocal Myalgia+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 19, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Phenotype and Burden of a Midfacial Segment Pain

Inclusion Criteria

Exclusion Criteria

Feasibility Testing of the "Face-Forward-Web" Program for Chronic Orofacial Pain

Effect of Occlusal Splint on Head and Neck Muscles in Patients With Bruxism and Myofascial Pain

Neurosurgical Outcome Network

Trigger Point Injections in Anterior Cervical Surgery

The Effectiveness of CBD and CBN in the Treatment of Facial Pain and Headache of Muscular Origin

Sphenopalatine Ganglion Pulsed Radiofrequency Treatment Outcomes